β¨ Government Appointments and Health Notices
21 AUGUST 2014 NEW ZEALAND GAZETTE, No. 96 2719
Foreign Affairs and Trade
Crown Entities Act 2004
Appointment to the New Zealand Antarctic Institute Board
Pursuant to section 28 of the Crown Entities Act 2004,
I appoint
Brian Roche
as a member of the New Zealand Antarctic Institute Board,
as established under the New Zealand Antarctic Institute Act
1996, for a term commencing on 31 August 2014 and
expiring on 1 July 2015.
Dated this Tuesday, the 19th day of August 2014.
HON MURRAY McCULLY, Minister of Foreign Affairs.
go5227
Health
Intellectual Disability (Compulsory Care and Rehabilitation) Act 2003
Appointment of Compulsory Care Co-ordinator
Under section 140 of the Intellectual Disability (Compulsory
Care and Rehabilitation) Act 2003, I appoint the following
person as a compulsory care co-ordinator for the named
geographical and operational areas listed below.
National coverage, including the Auckland/Northland,
Midlands, Central and Southern regions
Lizette Huitema
The appointment of the above-named person takes effect
on the date this notice is published in the New Zealand
Gazette and ends on 31 August 2019.
Dated at Wellington this 12th day of August 2014.
CHAI CHUAH, Acting Director-General of Health.
go5038
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Bosvate
Active Ingredient: Bisoprolol fumarate 1.25mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Chanelle Medical Limited, County Galway, Ireland
Product: Bosvate
Active Ingredient: Bisoprolol fumarate 3.75mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Chanelle Medical Limited, County Galway, Ireland
Product: Bosvate
Active Ingredient: Bisoprolol fumarate 7.5mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Chanelle Medical Limited, County Galway, Ireland
Product: Ceftriaxone
Active Ingredient: Ceftriaxone sodium 0.596g equivalent to Ceftriaxone 0.5g
Dosage Form: Powder for injection
New Zealand Sponsor: Deva Holdings NZ Limited
Manufacturer: Deva Holding A.S., Tekirdag, Turkey
Product: Ceftriaxone
Active Ingredient: Ceftriaxone sodium 1.193g equivalent to Ceftriaxone 1.0g
Dosage Form: Powder for injection
New Zealand Sponsor: Deva Holdings NZ Limited
Manufacturer: Deva Holding A.S., Tekirdag, Turkey
Next Page →
β¨ LLM interpretation of page content
π Appointment to the New Zealand Antarctic Institute Board
π External Affairs & Territories19 August 2014
Appointment, New Zealand Antarctic Institute Board, Crown Entities Act 2004
- Brian Roche, Appointed member of the New Zealand Antarctic Institute Board
- HON MURRAY McCULLY, Minister of Foreign Affairs
π₯ Appointment of Compulsory Care Co-ordinator
π₯ Health & Social Welfare12 August 2014
Appointment, Compulsory Care Co-ordinator, Intellectual Disability Act 2003
- Lizette Huitema, Appointed Compulsory Care Co-ordinator
- CHAI CHUAH, Acting Director-General of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Distribution, Consent, Medicines Act 1981
NZ Gazette 2014, No 96